{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:47:27Z","timestamp":1789753647876,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12016-015-8496-5","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:41:29Z","timestamp":1434933689000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features\u2014a Comprehensive Review"],"prefix":"10.1007","volume":"51","author":[{"given":"Yoshinao","family":"Muro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumitsu","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"8496_CR1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","volume":"24","author":"CA M\u00fchlen von","year":"1995","unstructured":"von M\u00fchlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323\u2013358","journal-title":"Semin Arthritis Rheum"},{"key":"8496_CR2","first-page":"263091","volume":"2014","author":"M Mahler","year":"2014","unstructured":"Mahler M, Pierangeli S, Meroni PL, Fritzler MJ (2014) Autoantibodies in systemic autoimmune disorders. J Immunol Res 2014:263091","journal-title":"J Immunol Res"},{"key":"8496_CR3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","volume":"24","author":"L Casciola-Rosen","year":"2012","unstructured":"Casciola-Rosen L, Mammen AL (2012) Myositis autoantibodies. Curr Opin Rheumatol 24:602\u2013608","journal-title":"Curr Opin Rheumatol"},{"key":"8496_CR4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","volume":"25","author":"SL Tansley","year":"2013","unstructured":"Tansley SL, Betteridge ZE, McHugh NJ (2013) The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr Opin Rheumatol 25:772\u2013777","journal-title":"Curr Opin Rheumatol"},{"key":"8496_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","volume":"47","author":"S Tansley","year":"2014","unstructured":"Tansley S, Gunawardena H (2014) The evolving spectrum of polymyositis and dermatomyositis\u2014moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47:264\u2013273","journal-title":"Clin Rev Allergy Immunol"},{"key":"8496_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"8496_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"8496_CR8","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, Sato T, Kiuchi T, Ohashi Y (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668\u2013674","journal-title":"J Rheumatol"},{"key":"8496_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","volume":"9","author":"IN Targoff","year":"1997","unstructured":"Targoff IN, Miller FW, Medsger TA Jr, Oddis CV (1997) Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 9:527\u2013535","journal-title":"Curr Opin Rheumatol"},{"key":"8496_CR10","first-page":"65","volume-title":"Cutaneous manifestations of rheumatic diseases","author":"RD Sontheimer","year":"2004","unstructured":"Sontheimer RD, Euwer RL, Costner MI (2004) Dermatomyositis. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 65\u2013103","edition":"2"},{"key":"8496_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","volume":"58","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Seshadri R, Sundberg J, Paller A, Pachman LM (2008) Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in juvenile dermatomyositis. Arthritis Rheum 58:571\u2013576","journal-title":"Arthritis Rheum"},{"key":"8496_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1525-1470.2011.01585.x","volume":"29","author":"SD Quinter","year":"2012","unstructured":"Quinter SD, Chiu YE, Lyon VB, Holland KE, Ruggeri SY, Drolet BA (2012) Inverse Gottron\u2019s papules: an unusual cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermato 29:641\u2013644","journal-title":"Pediatr Dermato"},{"key":"8496_CR13","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32:1719\u20131726","journal-title":"J Rheumatol"},{"key":"8496_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-91-4-577","volume":"91","author":"NI Stahl","year":"1979","unstructured":"Stahl NI, Klippel JH, Decker JL (1979) A cutaneous lesion associated with myositis. Ann Intern Med 91:577\u2013579","journal-title":"Ann Intern Med"},{"key":"8496_CR15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"8496_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2004.00115.x","volume":"20","author":"L Dourmishev","year":"2004","unstructured":"Dourmishev L, Meffert H, Piazena H (2004) Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed 20:230\u2013234","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8496_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0190-9622(07)80015-6","volume":"34","author":"M Kubo","year":"1996","unstructured":"Kubo M, Sato S, Kitahara H, Tsuchida T, Tamaki K (1996) Vesicle formation in dermatomyositis associated with gynecologic malignancies. J Am Acad Dermatol 34:391\u2013394","journal-title":"J Am Acad Dermatol"},{"key":"8496_CR18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaad.2006.05.005","volume":"55","author":"E Pope","year":"2006","unstructured":"Pope E, Janson A, Khambalia A, Feldman B (2006) Childhood acquired lipodystrophy: a retrospective study. J Am Acad Dermatol 55:947\u2013950","journal-title":"J Am Acad Dermatol"},{"key":"8496_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11926-014-0464-1","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, McHugh NJ (2014) Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies. Curr Rheumatol Rep 16:464","journal-title":"Curr Rheumatol Rep"},{"key":"8496_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1600-0560.1997.tb01458.x","volume":"24","author":"CM Magro","year":"1997","unstructured":"Magro CM, Crowson AN (1997) The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 24:543\u2013552","journal-title":"J Cutan Pathol"},{"key":"8496_CR21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796\u2013803","journal-title":"Arthritis Rheum"},{"key":"8496_CR22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore 70:360\u2013374","journal-title":"Medicine (Baltimore"},{"key":"8496_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","volume":"40","author":"K Komura","year":"2005","unstructured":"Komura K, Fujimoto M, Matsushita T, Kaji K, Kondo M, Hirano T, Orito H, Horikawa M, Hamaguchi Y, Hasegawa M, Takehara K, Sato S (2005) Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci 40:215\u2013217","journal-title":"J Dermatol Sci"},{"key":"8496_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, Komura K, Nakamura M, Kodera M, Suga N, Higashi A, Ogusu K, Tsutsui K, Furusaki A, Tanabe H, Sasaoka S, Muro Y, Yoshikawa M, Ishiguro N, Ayano M, Muroi E, Fujikawa K, Umeda Y, Kawase M, Mabuchi E, Asano Y, Sodemoto K, Seishima M, Yamada H, Sato S, Takehara K, Fujimoto M (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147:391\u2013398","journal-title":"Arch Dermatol"},{"key":"8496_CR25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MG Cruellas","year":"2013","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo) 68:909\u2013914","journal-title":"Clinics (Sao Paulo)"},{"key":"8496_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW, Childhood Myositis Heterogeneity Collaborative Study Group (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:223\u2013243","journal-title":"Medicine (Baltimore)"},{"key":"8496_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","volume":"18","author":"IN Targoff","year":"1992","unstructured":"Targoff IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin N Am 18:455\u2013482","journal-title":"Rheum Dis Clin N Am"},{"key":"8496_CR28","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8, e60442","journal-title":"PLoS One"},{"key":"8496_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, Matsushita T, Orito H, Hamaguchi Y, Yanaba K, Itoh M, Asano Y, Seishima M, Ogawa F, Sato S, Takehara K (2007) Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46:25\u201328","journal-title":"Rheumatology (Oxford)"},{"key":"8496_CR30","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54:3682\u20133689","journal-title":"Arthritis Rheum"},{"key":"8496_CR31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, Ishiguro N, Ueda-Hayakawa I, Asano Y, Ogawa F, Fujikawa K, Miyagi T, Mabuchi E, Hirose K, Akimoto N, Hatta N, Tsutsui K, Higashi A, Igarashi A, Seishima M, Hasegawa M, Takehara K (2012) Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 64:513\u2013522","journal-title":"Arthritis Rheum"},{"key":"8496_CR32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ (2008) Juvenile dermatomyositis research group UK. Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 47:324\u2013328","journal-title":"Rheumatology (Oxford)"},{"key":"8496_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","volume":"87","author":"A Bingham","year":"2008","unstructured":"Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM, Sebring N, O\u2019Hanlon TP, Ruiz-Hidalgo M, Turner M, Gordon LB, Laborda J, Bauer SR, Blackshear PJ, Imundo L, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study Group (2008) Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) 87:70\u201386","journal-title":"Medicine (Baltimore)"},{"key":"8496_CR34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","volume":"72","author":"DF Fiorentino","year":"2015","unstructured":"Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis. J Am Acad Dermatol 72:449\u2013455","journal-title":"J Am Acad Dermatol"},{"key":"8496_CR35","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/rheumatology\/kes073","volume":"51","author":"Y Muro","year":"2012","unstructured":"Muro Y, Ishikawa A, Sugiura K, Akiyama M (2012) Clinical features of anti-TIF1-\u03b1 antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-\u03b3 or anti-Mi-2 autoantibodies. Rheumatology (Oxford) 51:1508\u20131513","journal-title":"Rheumatology (Oxford)"},{"key":"8496_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65:25\u201334","journal-title":"J Am Acad Dermatol"},{"key":"8496_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22498","author":"NS Narang","year":"2015","unstructured":"Narang NS, Casciola-Rosen L, Li S, Chung L, Fiorentino DF (2015) Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res. doi: 10.1002\/acr.22498","journal-title":"Arthritis Care Res"},{"key":"8496_CR38","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, Arnold K, Yasin S, Moraitis E, Wedderburn LR, McHugh NJ, UK Juvenile Dermatomyositis Research Group (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 16:R138","journal-title":"Arthritis Res Ther"},{"key":"8496_CR39","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group, UK and Ireland (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814","journal-title":"Arthritis Rheum"},{"key":"8496_CR40","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","volume":"36","author":"G Espada","year":"2009","unstructured":"Espada G, Maldonado Cocco JA, Fertig N, Oddis CV (2009) Clinical and serologic characterization of an argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol 36:2547\u20132551","journal-title":"J Rheumatol"},{"key":"8496_CR41","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","volume":"53","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, McHugh NJ, Juvenile Dermatomyositis Research Group (2014) Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 53:2204\u20132208","journal-title":"Rheumatology (Oxford)"},{"key":"8496_CR42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"A Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L, Fiorentino D (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150:724\u2013729","journal-title":"JAMA Dermatol"},{"key":"8496_CR43","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M, Tincani A, Ross SJ, Chan JY, Pauley BA, Chan EK, Satoh M (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14:R97","journal-title":"Arthritis Res Ther"},{"key":"8496_CR44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, Inokoshi Y, Kawai K, Kanekura T, Habuchi M, Igarashi A, Sogame R, Hashimoto T, Koga T, Nishino A, Ishiguro N, Sugimoto N, Aoki R, Ando N, Abe T, Kanda T, Kuwana M, Takehara K, Fujimoto M (2012) Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71:710\u2013713","journal-title":"Ann Rheum Dis"},{"key":"8496_CR45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","volume":"51","author":"A Ishikawa","year":"2012","unstructured":"Ishikawa A, Muro Y, Sugiura K, Akiyama M (2012) Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology (Oxford) 51:1181\u20131187","journal-title":"Rheumatology (Oxford)"},{"key":"8496_CR46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ, UK Adult Onset Myositis Immunogenetic Collaboration (2009) Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target in UK Caucasian adult-onset myositis. Ann Rheum Dis 68:1621\u20131625","journal-title":"Ann Rheum Dis"},{"key":"8496_CR47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","volume":"72","author":"M Fujimoto","year":"2013","unstructured":"Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, Yamaoka T, Fujikawa K, Tsukada T, Sato K, Echigo T, Hasegawa M, Takehara K (2013) Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 72:151\u2013153","journal-title":"Ann Rheum Dis"},{"key":"8496_CR48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08916934.2012.755958","volume":"46","author":"Y Muro","year":"2013","unstructured":"Muro Y, Sugiura K, Akiyama M (2013) Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 46:279\u2013284","journal-title":"Autoimmunity"},{"key":"8496_CR49","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6ll\u0151si L, Dank\u00f3 K (2014) Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 13:1211\u20131219","journal-title":"Autoimmun Rev"},{"key":"8496_CR50","doi-asserted-by":"crossref","unstructured":"Muro Y, Sugiura K, Nara M, Sakamoto I, Suzuki N, Akiyama M (2015) High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis. Rheumatology (Oxford) (in press)","DOI":"10.1093\/rheumatology\/kev247"},{"key":"8496_CR51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","volume":"162","author":"I Marie","year":"2010","unstructured":"Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F (2010) Long-term outcome of patients with polymyositis\/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 162:337\u2013344","journal-title":"Br J Dermatol"},{"key":"8496_CR52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","volume":"17","author":"Y Muro","year":"2015","unstructured":"Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M (2015) Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Arthritis Res Ther 17:57","journal-title":"Arthritis Res Ther"},{"key":"8496_CR53","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.38866","volume":"66","author":"Y Muro","year":"2014","unstructured":"Muro Y, Nakashima R, Hosono Y, Sugiura K, Mimori T, Akiyama M (2014) Autoantibodies to DNA mismatch repair enzymes in polymyositis\/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis. Arthritis Rheumatol 66:3457\u20133462","journal-title":"Arthritis Rheumatol"},{"key":"8496_CR54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.autrev.2004.11.007","volume":"4","author":"H Ueki","year":"2005","unstructured":"Ueki H (2005) Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev 4:219\u2013223","journal-title":"Autoimmun Rev"},{"key":"8496_CR55","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","volume":"179","author":"LA Casciola-Rosen","year":"1994","unstructured":"Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317\u20131330","journal-title":"J Exp Med"},{"key":"8496_CR56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.185.1.71","volume":"185","author":"L Casciola-Rosen","year":"1997","unstructured":"Casciola-Rosen L, Wigley F, Rosen A (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 185:71\u201379","journal-title":"J Exp Med"},{"key":"8496_CR57","doi-asserted-by":"crossref","first-page":"34976","DOI":"10.1074\/jbc.M805383200","volume":"283","author":"CJ Burd","year":"2008","unstructured":"Burd CJ, Kinyamu HK, Miller FW, Archer TK (2008) UV radiation regulates Mi-2 through protein translation and stability. J Biol Chem 283:34976\u201334982","journal-title":"J Biol Chem"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8496-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8496-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T10:27:29Z","timestamp":1652524049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8496-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["8496"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8496-5","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]}}}